Leaflet NYLEX 100UI / dose nasal spray, solution
Indicated for: osteoporosis; hypercalcemia
Route of administration: nasal
Substance: calcitonin (salmon) (hormone)
ATC: H05BA01 (Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Calcitonin preparations)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Salmon-derived calcitonin is a more potent form of the hormone calcitonin, used for the treatment of osteoporosis, Paget's disease, and hypercalcemia. It works by inhibiting bone resorption and regulating blood calcium levels.
The salmon-derived form is preferred due to its increased efficacy compared to human calcitonin. It is available as injections or nasal spray and is often used as an adjunct therapy.
Salmon calcitonin can reduce bone pain and improve the quality of life for patients with bone-related conditions. It is important that the treatment is administered under medical supervision to minimize risks.
Side effects include nausea, facial flushing, nasal irritation, or allergic reactions. Long-term use is limited due to the risk of cancer associated with prolonged treatment.
General data about NYLEX 100UI / dose
- Substance: calcitonin (salmon)
- Date of last drug list: 01-01-2015
- Commercial code: W57934001
- Concentration: 100UI / dose
- Pharmaceutical form: nasal spray, solution
- Quantity: 1
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for calcitonin (salmon)
Concentrations available for calcitonin (salmon)
- 100UI
- 100UI/dose
- 100UI/ml
- 200UI/dose
- 50UI
- 50UI/ml